
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current LIVN market cap is 2.22B. The company's latest EPS is USD 0.3270 and P/E is 125.17.
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 286.11M | 310.09M | 294.91M | 318.58M | 318.12M |
Operating Income | 4.46M | 2.11M | 16.25M | 40.17M | 35.62M |
Net Income | -7.32M | 16.29M | -41.94M | 16.33M | 32.95M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 1.08B | 934.24M | 1.04B | 1.02B | 1.15B |
Operating Income | -168.51M | -89.7M | -61.02M | -76.75M | 23.02M |
Net Income | -155.18M | -345.01M | -135.82M | -86.25M | 17.75M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 2.33B | 2.43B | 2.46B | 2.45B | 2.52B |
Total Liabilities | 1.1B | 1.15B | 1.24B | 1.21B | 1.21B |
Total Equity | 1.23B | 1.28B | 1.22B | 1.24B | 1.31B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 2.41B | 2.41B | 2.2B | 2.29B | 2.43B |
Total Liabilities | 1.03B | 1.29B | 906.31M | 1.09B | 1.15B |
Total Equity | 1.38B | 1.12B | 1.29B | 1.21B | 1.28B |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 20.96M | 74.9M | 9.98M | 53.34M | 104.33M |
Investing | -28.19M | -40.3M | -6.36M | -18.93M | -37.45M |
Financing | 26.5M | 21.5M | 37.15M | 25.28M | 22M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -91.14M | -79.42M | 102.54M | 69.92M | 74.91M |
Investing | -41.29M | -41.84M | 36.9M | -38.41M | -40.33M |
Financing | 146.58M | 310.76M | -181.48M | 280.13M | 21.48M |
Market Cap | 2.22B |
Price to Earnings Ratio | 125.17 |
Price to Sales Ratio | 1.93 |
Price to Cash Ratio | 8.34 |
Price to Book Ratio | 1.74 |
Dividend Yield | - |
Shares Outstanding | 54.3M |
Average Volume (1 week) | 1.34M |
Average Volume (1 Month) | 646.19k |
52 Week Change | -27.31% |
52 Week High | 64.475 |
52 Week Low | 40.51 |
Spread (Intraday) | 7.75 (16.15%) |
Company Name | LivaNova PLC |
Address |
20 eastbourne terrace london W2 6LG |
Website | https://www.livanova.com |
Industry | electromedical apparatus (3845) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions